The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities

Aksoy, Berna; Altaykan-Hapa, Aslı; Egemen, Didem; Karagöz, Filiz; Atakan, Nilgün

doi:10.1111/j.1365-2133.2010.09894.x

Cited by 115 publications

(116 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…3 In contrast, a previous study found that, of the secondary features, only burning/stinging was significantly correlated with ETR while severity of this feature was associated with OC. 14 In that study, however, PPR was considered to be a subgroup of ETR, thereby reducing the sensitivity of detecting differences between ETR and PPR. The prevalence of ocular symptoms in 36% of this cohort is within the range of previous recent investigations from dermatology clinics.…”

Section: Discussionmentioning

confidence: 99%

An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes

et al. 2013

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes

et al. 2013

View full text Add to dashboard Cite

“…The DLQI questionnaire is a reliable and valid instrument that is quite sensitive to QoL changes brought about by various treatment options. 146,147 The rosacea-specific QoL and Skindex-29 measure which characteristics of rosacea affect the patient's life the most. Interestingly, flushing was found to be the most troubling symptom reported by patients affected by rosacea, stressing the importance of treating both the cosmetic and medical aspects of this condition.…”

Section: Patient-focused Perspectives: Quality Of Life and Patient Samentioning

confidence: 99%

Update on the Management of Rosacea

Weinkle

Doktor

Emer

2015

Plastic Surgical Nursing

View full text Add to dashboard Cite

Abstract:Refining diagnostic criteria has identified key characteristics differentiating rosacea, a chronic skin disorder, from other common cutaneous inflammatory conditions. The current classification system developed by the National Rosacea Society Expert Committee consists of erythematotelangiectatic, papulopustular, phymatous, and ocular subtypes. Each subtype stands as a unique entity among a spectrum, with characteristic symptoms and physical findings, along with an intricate pathophysiology. The main treatment modalities for rosacea include topical, systemic, laser, and light therapies. Topical brimonidine tartrate gel and calcineurin inhibitors are at the forefront of topical therapies, alone or in combination with traditional therapies such as topical metronidazole or azelaic acid and oral tetracyclines or isotretinoin. Vascular laser and intense pulsed light therapies are beneficial for the erythema and telangiectasia, as well as the symptoms (itching, burning, pain, stinging, swelling) of rosacea. Injectable botulinum toxin, topical ivermectin, and microsecond long-pulsed neodymium-yttrium aluminum garnet laser are emerging therapies that may prove to be extremely beneficial in the future. Once a debilitating disorder, rosacea has become a well known and manageable entity in the setting of numerous emerging therapeutic options. Herein, we describe the treatments currently available and give our opinions regarding emerging and combination therapies.

show abstract

“…It is important to remember that rosacea can lead to a lot of negative psychological effect in the patient and this in turn can lead to aggravation of the primary disease. 6 To break this vicious cycle, an effective treatment of the primary disease is of paramount importance. 6 In addition to the therapeutic options employed in the disease, avoidance of triggering factors, UV-protection and proper skin care are equally important in the management of rosacea.…”

Section: Introductionmentioning

confidence: 99%

Rosacea: an update on therapeutic options

Majid

Bhat²

2018

Int J Res Dermatol

View full text Add to dashboard Cite

Rosacea is a common inflammatory skin disease affecting the face usually in middle-aged individuals. The disorder is associated with a lot of psychological impact on the quality of life of the affected patient. Treatment options for this skin disease range from topical treatment options to systemic agents and even lasers. This paper will review the current and some of the upcoming treatment options for this chronic skin disease.

show abstract

The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities

Cited by 115 publications

References 15 publications

An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes

An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes

Update on the Management of Rosacea

Rosacea: an update on therapeutic options

Contact Info

Product

Resources

About